Serum Chemokines and Quality of Life among Patients with Endometriomas and Teratomas
Background: Endometriosis is a chronic inflammatory condition characterized by the presence of endometrial tissue outside the uterus, which can cause pelvic pain, infertility, and other symptoms. The disease may manifest as superficial peritoneal or deep-infiltrating endometriosis or as ovarian endo...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2022-09-01
|
| Series: | Clinical and Experimental Obstetrics & Gynecology |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/CEOG/49/9/10.31083/j.ceog4909207 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849324718430093312 |
|---|---|
| author | Małgorzata Wojciechowska Karolina Chmaj-Wierzchowska Katarzyna Wszołek Kinga Bednarek Aleksandra Jasielska Ilona Parda Paweł Rzymski Maciej Wilczak |
| author_facet | Małgorzata Wojciechowska Karolina Chmaj-Wierzchowska Katarzyna Wszołek Kinga Bednarek Aleksandra Jasielska Ilona Parda Paweł Rzymski Maciej Wilczak |
| author_sort | Małgorzata Wojciechowska |
| collection | DOAJ |
| description | Background: Endometriosis is a chronic inflammatory condition characterized by the presence of endometrial tissue outside the uterus, which can cause pelvic pain, infertility, and other symptoms. The disease may manifest as superficial peritoneal or deep-infiltrating endometriosis or as ovarian endometriomas. Although the mechanisms associated with the regulation and production of inflammatory mediators in endometriosis have been widely investigated, the precise mechanism responsible for inflammation-induced pain remains unclear, and the findings related to the cytokine expression profile and the location of cytokines in cells are contradictory. The intensity of pain experienced by endometriosis patients is not proportional to the degree and severity of their disease. Pain has a significant impact on women suffering from endometriosis. Methods: The following inclusion criteria to the study were: presence of endometriomas vs teratomas, negative pregnancy test result, no prior obstetric and infertility treatment, and good health condition with no diseases or coagulation disorders. Blood samples were collected from all patients. The serum levels of chemokines were determined by ELISA. The Nottingham Health Profile (NHP) questionnaire was made. Results: The median serum levels of chemokines: Monocyte Chemoattractant Protein 1 (MCP-1) and Monocyte Chemoattractant Protein 3 (MCP-3) were statistically higher in the endometriomas group compared to the other two groups. In the NHP questionnaire the comparison of the subjective health dimensions in individual groups showed that the patients in the endometriomas group experienced a significantly higher intensity of “PAIN” compared to other groups. Correlation analysis between NHP dimensions and serum chemokine levels: spearman’s rank correlation analysis indicated a statistically significant relationship between the “VITAL ENERGY” dimension and the level of MCP-2 (r = –0.295; p = 0.022), MCP-3 (r = 0.254; p = 0.050), and RANTES (r = –0.353; p = 0.006); between the “EMOTIONS” dimension and the level of MCP-3 (r = 0.262; p = 0.043); and between the “INCONVENIENCE IN DAILY LIFE” dimension and the level of Eotaxin-1 (r = –0.283; p = 0.028) and CCL13 (r = –0.287; p = 0.026). Conclusions: The chemokines serum levels (i.e., MCP-1 and MCP-3) and intensity of “PAIN” were statistically higher in the endometriomas compared to the teratomas group of women. Therefore, understanding their role in endometriosis-related pain could help in the development of novel, multidisciplinary treatments. |
| format | Article |
| id | doaj-art-c1329c12097b4932be69e0d1dddb36a7 |
| institution | Kabale University |
| issn | 0390-6663 |
| language | English |
| publishDate | 2022-09-01 |
| publisher | IMR Press |
| record_format | Article |
| series | Clinical and Experimental Obstetrics & Gynecology |
| spelling | doaj-art-c1329c12097b4932be69e0d1dddb36a72025-08-20T03:48:36ZengIMR PressClinical and Experimental Obstetrics & Gynecology0390-66632022-09-0149920710.31083/j.ceog4909207S0390-6663(22)01856-5Serum Chemokines and Quality of Life among Patients with Endometriomas and TeratomasMałgorzata Wojciechowska0Karolina Chmaj-Wierzchowska1Katarzyna Wszołek2Kinga Bednarek3Aleksandra Jasielska4Ilona Parda5Paweł Rzymski6Maciej Wilczak7Department of Maternal and Child Health, Poznan University of Medical Sciences, 61-701 Poznan, PolandDepartment of Maternal and Child Health, Poznan University of Medical Sciences, 61-701 Poznan, PolandDepartment of Maternal and Child Health, Poznan University of Medical Sciences, 61-701 Poznan, PolandDepartment of Maternal and Child Health, Poznan University of Medical Sciences, 61-701 Poznan, PolandFaculty of Psychology and Cognitive Science, Adam Mickiewicz University, 61-712 Poznan, PolandDepartment of Maternal and Child Health, Poznan University of Medical Sciences, 61-701 Poznan, PolandDepartment of Maternal and Child Health, Poznan University of Medical Sciences, 61-701 Poznan, PolandDepartment of Maternal and Child Health, Poznan University of Medical Sciences, 61-701 Poznan, PolandBackground: Endometriosis is a chronic inflammatory condition characterized by the presence of endometrial tissue outside the uterus, which can cause pelvic pain, infertility, and other symptoms. The disease may manifest as superficial peritoneal or deep-infiltrating endometriosis or as ovarian endometriomas. Although the mechanisms associated with the regulation and production of inflammatory mediators in endometriosis have been widely investigated, the precise mechanism responsible for inflammation-induced pain remains unclear, and the findings related to the cytokine expression profile and the location of cytokines in cells are contradictory. The intensity of pain experienced by endometriosis patients is not proportional to the degree and severity of their disease. Pain has a significant impact on women suffering from endometriosis. Methods: The following inclusion criteria to the study were: presence of endometriomas vs teratomas, negative pregnancy test result, no prior obstetric and infertility treatment, and good health condition with no diseases or coagulation disorders. Blood samples were collected from all patients. The serum levels of chemokines were determined by ELISA. The Nottingham Health Profile (NHP) questionnaire was made. Results: The median serum levels of chemokines: Monocyte Chemoattractant Protein 1 (MCP-1) and Monocyte Chemoattractant Protein 3 (MCP-3) were statistically higher in the endometriomas group compared to the other two groups. In the NHP questionnaire the comparison of the subjective health dimensions in individual groups showed that the patients in the endometriomas group experienced a significantly higher intensity of “PAIN” compared to other groups. Correlation analysis between NHP dimensions and serum chemokine levels: spearman’s rank correlation analysis indicated a statistically significant relationship between the “VITAL ENERGY” dimension and the level of MCP-2 (r = –0.295; p = 0.022), MCP-3 (r = 0.254; p = 0.050), and RANTES (r = –0.353; p = 0.006); between the “EMOTIONS” dimension and the level of MCP-3 (r = 0.262; p = 0.043); and between the “INCONVENIENCE IN DAILY LIFE” dimension and the level of Eotaxin-1 (r = –0.283; p = 0.028) and CCL13 (r = –0.287; p = 0.026). Conclusions: The chemokines serum levels (i.e., MCP-1 and MCP-3) and intensity of “PAIN” were statistically higher in the endometriomas compared to the teratomas group of women. Therefore, understanding their role in endometriosis-related pain could help in the development of novel, multidisciplinary treatments.https://www.imrpress.com/journal/CEOG/49/9/10.31083/j.ceog4909207endometriomasteratomasquality of lifehealth problemsnottingham heath profilesars-cov-2 pandemic |
| spellingShingle | Małgorzata Wojciechowska Karolina Chmaj-Wierzchowska Katarzyna Wszołek Kinga Bednarek Aleksandra Jasielska Ilona Parda Paweł Rzymski Maciej Wilczak Serum Chemokines and Quality of Life among Patients with Endometriomas and Teratomas Clinical and Experimental Obstetrics & Gynecology endometriomas teratomas quality of life health problems nottingham heath profile sars-cov-2 pandemic |
| title | Serum Chemokines and Quality of Life among Patients with Endometriomas and Teratomas |
| title_full | Serum Chemokines and Quality of Life among Patients with Endometriomas and Teratomas |
| title_fullStr | Serum Chemokines and Quality of Life among Patients with Endometriomas and Teratomas |
| title_full_unstemmed | Serum Chemokines and Quality of Life among Patients with Endometriomas and Teratomas |
| title_short | Serum Chemokines and Quality of Life among Patients with Endometriomas and Teratomas |
| title_sort | serum chemokines and quality of life among patients with endometriomas and teratomas |
| topic | endometriomas teratomas quality of life health problems nottingham heath profile sars-cov-2 pandemic |
| url | https://www.imrpress.com/journal/CEOG/49/9/10.31083/j.ceog4909207 |
| work_keys_str_mv | AT małgorzatawojciechowska serumchemokinesandqualityoflifeamongpatientswithendometriomasandteratomas AT karolinachmajwierzchowska serumchemokinesandqualityoflifeamongpatientswithendometriomasandteratomas AT katarzynawszołek serumchemokinesandqualityoflifeamongpatientswithendometriomasandteratomas AT kingabednarek serumchemokinesandqualityoflifeamongpatientswithendometriomasandteratomas AT aleksandrajasielska serumchemokinesandqualityoflifeamongpatientswithendometriomasandteratomas AT ilonaparda serumchemokinesandqualityoflifeamongpatientswithendometriomasandteratomas AT pawełrzymski serumchemokinesandqualityoflifeamongpatientswithendometriomasandteratomas AT maciejwilczak serumchemokinesandqualityoflifeamongpatientswithendometriomasandteratomas |